Workflow
Focus: Lilly weight-loss pill could be FDA-approved by year-end
礼来礼来(US:LLY) Reuters·2025-09-16 18:09

药物审批进展 - 礼来实验性减肥药丸可能通过1至2个月的快速审查流程获得加速审批 [1] - 快速审查流程由美国食品药品监督管理局近期启动 [1]